Naltrexone in AUD Reward Drinkers

Abroad (travel likely)RecruitingPHASE4

Conditions

Alcohol Use Disorder · Alcoholism

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Pennsylvania Center for Studies of Addiction, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Timothy S. Pond, M.P.H.) · timpond@pennmedicine.upenn.edu · 215-746-1959
Contact: Study coordinator (Rachel Weyl, BS) · rachel.weyl@Pennmedicine.upenn.edu · 215-746-1902
Contact: Principal Investigator (Henry R. Kranzler, M.D.)
Kyle Kampman, M.D. (Sub-investigator)
Corinde Wiers, Ph.D. (Sub-investigator)

Study leads

Henry R Kranzler, MD
Principal Investigator
University of Pennsylvania

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

Alcohol Use Disorder

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Scottsdale, United States

Guanfacine for Alcohol Use Disorder (AUD)

Alcohol Use Disorder

Abroad (travel likely)RecruitingPHASE2

Indianapolis, United States · Newark, United States

Human Laboratory Study of Apremilast for Alcohol Use Disorder

Alcohol Use Disorder · Alcohol Misuse

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States · Aurora, United States

Study of NTX-2001 on Alcohol Consumption in Alcohol Use Disorder

Alcohol Use Disorder

Abroad (travel likely)RecruitingPHASE1

New Haven, United States